GAUDIUMIVF.NS
GAUDIUMIVF · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for GAUDIUMIVF.NS quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Results Change Summary quarter-on-quarter and year-on-year filing evidence
Generate an evidence-linked summary of revenue, margin, profit, debt, cash and operating cash flow changes.
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Press Release
16 Jul 2026
Commencement of commercial production/operations
16 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
11 Jul 2026
Trading Window
26 Jun 2026
Updates
26 Jun 2026
Outcome of Board Meeting
25 Jun 2026
Disclosure under SEBI Takeover Regulations
22 Jun 2026
Disclosure under SEBI Takeover Regulations
17 Jun 2026
Disclosure under SEBI Takeover Regulations
17 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
09 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
29 May 2026
Copy of Newspaper Publication
29 May 2026
Investor Presentation
29 May 2026
Press Release
29 May 2026
Outcome of Board Meeting
29 May 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
No corporate actions available from NSE right now.
Board Meetings
28 May 2026
GAUDIUM IVF AND WOMEN HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 .
28 May 2026
Gaudium IVF and Women Health Limited has informed the Exchange that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026, inter alia, to consider and approve the Audited Standalone and Consolidated Financial Statements/Results of the Company for the quarter and year ended March 31, 2026.
18 Mar 2026
GAUDIUM IVF AND WOMEN HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 18-Mar-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
18 Mar 2026
GAUDIUM IVF AND WOMEN HEALTH LIMITED has informed the Exchange about Board Meeting to be held on 18-Mar-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
18 Mar 2026
To consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31, 2025